Meeting
2020 Gastrointestinal Cancers Symposium
Total skeletal, psoas, and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma.
Authors
Yu Yun Shao
Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
Yu Yun Shao , Chih-Horng Wu , Po-Chin Liang , Chih-Hung Hsu , Tiffany Ting-Fang Shih
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 568)
Abstract #
568
Poster Bd #
E7
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Prognostic and predictive factors in patients treated with ramucirumab (RAM) with advanced hepatocellular carcinoma (aHCC) and elevated alpha-fetoprotein (AFP): Results from two phase III trials.
First Author: Josep M. Llovet
Poster
2020 Gastrointestinal Cancers Symposium
IGF-1 Child-Turcotte-Pugh score as a predictor of overall survival to therapy in CTP-A, BCLC stage C patients with advanced hepatocellular carcinoma.
First Author: Yehia I. Abugabal
Poster
2019 ASCO Annual Meeting
IGF-Child-Pugh score as a predictor of treatment outcome in advanced hepatocellular carcinoma patients treated with sorafenib.
First Author: Yehia I. Abugabal
Poster
2019 Gastrointestinal Cancers Symposium
IGF-Child-Pugh score as a predictor of treatment outcome in Child-Pugh A, advanced hepatocellular carcinoma patients undergoing sorafenib therapy.
First Author: Yehia I. Abugabal